Line 13: | Line 13: | ||
<li><a href="https://2016.igem.org/Team:Glasgow/beta-carotene">β-carotene Synthesis</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/beta-carotene">β-carotene Synthesis</a></li> | ||
<li><a href="https://2016.igem.org/Team:Glasgow/Chassis">Chassis</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/Chassis">Chassis</a></li> | ||
+ | <li><a href="https://2016.igem.org/Team:Glasgow/Description">Characterising amilCP</a></li> | ||
<li><a href="https://2016.igem.org/Team:Glasgow/Transcriptomics">Transcriptomics</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/Transcriptomics">Transcriptomics</a></li> | ||
<li><a href="https://2016.igem.org/Team:Glasgow/SIM">Self-Inactivating Mechanism</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/SIM">Self-Inactivating Mechanism</a></li> | ||
Line 33: | Line 34: | ||
<li><a href="https://2016.igem.org/Team:Glasgow/Engagement">Outreach</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/Engagement">Outreach</a></li> | ||
<li><a href="https://2016.igem.org/Team:Glasgow/Measurement">Measurement</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/Measurement">Measurement</a></li> | ||
− | |||
<li><a href="https://2016.igem.org/Team:Glasgow/Integrated_Practices">Integrated Human Practices</a></li> | <li><a href="https://2016.igem.org/Team:Glasgow/Integrated_Practices">Integrated Human Practices</a></li> | ||
</ul> | </ul> |
Revision as of 16:52, 18 October 2016